

Michael D. O'Halleran: Executive Profile & Biography - Bloomberg









































  





















































































July 23, 2017 12:47 PM ET
Insurance

Company Overview of Aon Benfield Global, Inc.



SnapshotPeople 




OverviewBoard MembersCommittees



Executive Profile
Michael D. O'Halleran  Executive Chairman, Aon Benfield Global, Inc.AgeTotal Calculated CompensationThis person is connected to 11 Board Members in 11 different organizations across 12 different industries.See Board Relationships67--
Background

		Mr. Michael D. O'Halleran, also known as Mike, serves as an Executive Chairman of Aon Benfield Inc., Aon Benfield Limited and Aon Benfield Global, Inc. Mr. O'Halleran serves as an Executive Chairman of Aon Benfield Group Limited and served as its Chairman. He served as Senior Executive Vice President of Aon plc since September 2004. He served as the Chief Executive Officer of Aon Benfield Group Limited. He has more than 33 years of experience in the insurance and reinsurance ... industries. He founded Aon Re Global in 1987. He served as the Chief Financial Officer of Hewlett Packard. He served as the President and Chief Operating Officer of Aon Corporation from April 16, 1999 to September 30, 2004. He served as the President and Chief Operating Officer of Aon Group Inc., a subsidiary of Aon Corporation from 1995 to September 30, 2004. He served in other significant senior management positions within AON group of companies since 1987. He served as a Senior Executive with well-known companies within the insurance industry, including Wausau Insurance Companies, General Reinsurance and Alexander Re. He serves as a Co-Chairman of World Business Chicago and Trustee of Dublin City University in Dublin, Ireland. He has been a Director of Allegiance Corporation since 1996 and NuVasive, Inc. since August 1, 2016. He serves as a Director at OptiMark US Equities, Inc. and World Business Chicago. He serves as a Trustee of Lake Forest College. He served as an Independent Director of CareFusion Corporation from 2009 to March 17, 2015. He served as a Director of Cardinal Health, Inc. from 1999 to 2009. He served as a Director of Aon Corporation and Cardinal Health 414, LLC since 1999. He served as a Director of Care Fusion, Inc. and Benfield Group Ltd. He is a Director of a number of charitable and educational organizations, including Providence-St. Mel High School and the Angus Robinson Jr. He is a Member of the Economic Club of Chicago and the World President Organization. Mr. O'Halleran has a degree in Accounting and Finance from the University of Wisconsin-Whitewater.Read Full Background




Corporate Headquarters
Aon CenterChicago, Illinois 60601United StatesPhone: 312-381-3040Fax: 312-381-3045
Board Members Memberships
Board MemberOptiMark US Equities, Inc.TrusteeLake Forest CollegeExecutive ChairmanAon Benfield Group LimitedExecutive ChairmanAon Benfield Global, Inc.DirectorWorld Business ChicagoExecutive ChairmanAon Benfield Inc.Executive ChairmanAon Benfield Limited1996-PresentDirectorAllegiance Corporation1999-PresentDirectorCardinal Health 414, LLC2016-PresentDirectorNuVasive, Inc.
Education
Unknown/Other Education University of Wisconsin, Whitewater
Other Affiliations
NuVasive, Inc.OptiMark US Equities, Inc.Aon plcCardinal Health, Inc.Allegiance CorporationCardinal Health 414, LLCLake Forest CollegeAon Benfield Group LimitedUniversity of Wisconsin, WhitewaterCare Fusion, Inc.World Business ChicagoCareFusion CorporationAon Benfield Inc.Aon Benfield Limited


Annual Compensation
				There is no Annual Compensation data available.
				Stocks Options
				There is no Stock Options data available.
				Total Compensation
				There is no Total Compensation data available.
			



Request Profile Update
















 












The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking 
	here.




Stock Quotes


Market data is delayed at least 15 minutes.







Company Lookup



COMPETITOR COMPENSATIONThere is no Competitor Compensation data available.










Sponsored Financial Commentaries

Sponsored Links






Browse Companies
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 | 
0
1
2
3
4
5
6
7
8
9






Request Profile Update

						Only a company representative may request an update for the company profile. Documentation will be required.
					  
To contact Aon Benfield Global, Inc., please visit .  Company data is provided by S&P Global Market Intelligence.  Please use this form to report any data issues.
					  


Information Missing - Please enter your information in the following field(s): 




Company Name

Your Name*

Your E-Mail Address*

Your Phone Number*

Type of Data*


Overview
Executives
Key developments
Similar companies
Transactions


Update Needed*

All data changes require verification from public sources.  Please include the correct value or values and a source where we can verify.


Cancel


Submit






Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.


Close





























Michael O'Halleran






































Risk | 
		

		
			Reinsurance | 
		
		
			Human Resources

Careers


















Reinsurance










Home
Products & Services 
  
    



By Expertise
    
      

Analytics-Catastrophe Management-Actuarial-Market Analysis-Rating Agency Advisory-Risk & Capital Strategy-Aon Benfield Research-Impact ForecastingAon Securities-Pathwise Solutions GroupClaims. Contract Wording & Client ServicesFacultative ReinsuranceAon InpointTreaty ReinsuranceThought Leadership / Papers
By Solution
    
      

Accident, Health and LifeAgricultureAviationCommercial AutoConstruction and EngineeringCredit and Financial RisksCyberD & O / E & OEnvironmentalGeneral Liability / Umbrella / ClashGlobal ReSpecialtyLawyers Professional LiablityMarine, Specialty, CompositeMedical Professional LiabilityMGA and Program SolutionsMutual Insurance Non-Marine / RetroPropertyReSolutionsSpecialty CasualtySurety and FidelityTerrorismWorkers' CompensationSpecialty Practice GroupsFacultative ReinsuranceTreaty ReinsuranceThought Leadership / Papers
By Products &Tools
    
      

Client PortalsABConnectFAConnectImpactOnDemandMarketReViewImpact ForecastingReMetricaCat ScoreThought Leadership / Papers


The One Brief is Aon's weekly guide to the most important issues affecting business, the economy and people's lives in the world today.Read The One Brief


About Aon Benfield
  
     




By Products &Tools
    
      


Careers
Company Overview
Leadership
Empower Results
Events
Awards
Investor Relations
Media Center
Team Member Login





The One Brief is Aon's weekly guide to the most important issues affecting business, the economy and people's lives in the world today.Read The One Brief


Contact Us
Choose Country/Office















Michael O'Halleran
Executive Chairman, Aon Benfield
Senior Executive Vice President, Aon plc

Michael D. O'Halleran is Executive Chairman of Aon Benfield and Senior Executive Vice President of Aon plc. Mike was appointed to lead Aon's reinsurance division at its inception in 1987. Previously, he held several senior operating positions at Aon. Before joining the Firm, he was a senior executive with well-known companies within the insurance industry, including Wausau Insurance Companies, General Reinsurance and Alexander Re. Mike has more than 33 years of experience in the insurance and reinsurance industries. He is also a member of the Economic Club of Chicago and the World Presidents Organization.























Global Home
			
	
		|
		
		
				Careers
			
	
		|
		
		
				Site Map
			
	
		|
		
		
				Investor Relations
			
	
		|
		
		
				Legal
			
	
		|
		
		
				Privacy
			
	
		|
		
		
				Cookie Notice

	
			|
                
                            © 2017 Aon plc

























Michael D. O'Halleran and Patrick S. Miles Elected to NuVasive Board of Directors - MarketWatch

















































Bulletin






Investor Alert







Tokyo Markets Open in:



US Market Snapshot
Currencies
Commodities




















press release


					Aug. 1, 2016, 7:00 a.m. EDT
				
Michael D. O'Halleran and Patrick S. Miles Elected to NuVasive Board of Directors
























Aug 01, 2016 (Marketwired via COMTEX) --
SAN DIEGO, CA--(Marketwired - August 01, 2016) - NuVasive, Inc.                 

/quotes/zigman/92312/composite NUVA
-1.47%


, a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the appointment of Mike O'Halleran and Pat Miles to the Company's Board of Directors effective August 1, 2016. Mr. O'Halleran will serve as an independent director of the Company and member of the Board's Audit Committee. Mr. Miles currently serves as president and chief operating officer (COO) of NuVasive, Inc. and is a member of the Company's executive management team. Mr. Miles will serve as a non-independent member of the Board.


                                        








"We are pleased to welcome Mike and Pat to our Board of Directors as we work to advance the long-term strategic goals of NuVasive. Mike and Pat are extremely accomplished leaders who bring a wealth of experience and judgment to our Board," said Gregory T. Lucier, chairman and chief executive officer of NuVasive, Inc. "Mike's extensive business experience and Pat's deep understanding of the dynamics of the spine industry will complement the skills of our current Board and add value to the future of the Company."


                                        








With more than 40 years of business experience, Mr. O'Halleran currently serves as the executive chairman of Aon Benfield and senior vice president of Aon, plc, a provider of risk management, insurance and consulting services. Mr. O'Halleran joined the Aon group of companies in 1987 to lead its reinsurance division and since that time, has served in several significant management positions including president and chief operating officer of Aon Corporation, and since August 2007, as the executive chairman of Aon Benfield. Prior to joining Aon, he was a senior executive with well-known companies in the insurance industry. Mr. O'Halleran brings extensive healthcare and medical device governance experience, having been a long-standing director of Cardinal Health and later CareFusion. Mr. O'Halleran has a degree in Accounting and Finance from the University of Wisconsin-Whitewater.


                                        








As an orthopedic and spine industry veteran with more than 25 years' experience, Mr. Miles' appointment to the Board reflects the impact he brings to the future of NuVasive. Mr. Miles has been with NuVasive since 2001, and has held multiple roles with increasing responsibility in the areas of operations, research, surgeon education, product development, and marketing. In 2015, he was appointed president and COO, responsible for leadership of NuVasive's global products and services, as well as operational duties, including customer fulfillment, manufacturing, supply chain management and quality engineering. Prior to joining NuVasive, he held positions at Medtronic Sofamor Danek and Smith & Nephew. Mr. Miles received a B.S. in Finance from Mercer University.


                                        








About NuVasive


                                        








NuVasive, Inc.                 

/quotes/zigman/92312/composite NUVA
-1.47%


 is a world leader in minimally invasive, procedurally-integrated spine solutions. From complex spinal deformity to degenerative spinal conditions, NuVasive is transforming spine surgery with innovative technologies designed to deliver reproducible and clinically proven surgical outcomes. NuVasive's highly differentiated, procedurally-integrated solutions include access instruments, implantable hardware and software systems for surgical planning and reconciliation technology that centers on achieving the global alignment of the spine. With $811 million in revenues (2015), NuVasive has an approximate 1,900 person workforce in more than 40 countries around the world. For more information, please visit nuvasive.com.


                                        








Forward-Looking Statements


                                        








NuVasive cautions you that statements included in this news release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, among others, risks associated with acceptance of the Company's surgical products and procedures by spine surgeons, development and acceptance of new products or product enhancements, clinical and statistical verification of the benefits achieved via the use of NuVasive's products (including the iGA™ platform), the Company's ability to effectually manage inventory as it continues to release new products, its ability to recruit and retain management and key personnel, and the other risks and uncertainties described in NuVasive's news releases and periodic filings with the Securities and Exchange Commission. NuVasive's public filings with the Securities and Exchange Commission are available at         www.sec.gov
. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.


                                        








Investor Contact:
Suzanne Hatcher
NuVasive, Inc.
858-458-2240
Email contact
Media Contact:
Michael Farrington
NuVasive, Inc.
858-909-1940
Email contact


                                        








© 2016 Nasdaq, Inc. All rights reserved.
                    



/quotes/zigman/92312/composite 





 Add to watchlist
                    
NUVA




NuVasive Inc.


                US
                
                    : U.S.: Nasdaq
                
            




$
79.92



-1.19
-1.47%




Volume: 567,953
July 21, 2017 4:00p






P/E Ratio82.39
Dividend YieldN/A




Market Cap$4.05 billion
Rev. per Employee$453,105





 









 





/quotes/zigman/92312/composite 





 Add to watchlist
                    
NUVA




NuVasive Inc.


                US
                
                    : U.S.: Nasdaq
                
            




$
79.92



-1.19
-1.47%




Volume: 567,953
July 21, 2017 4:00p






P/E Ratio82.39
Dividend YieldN/A




Market Cap$4.05 billion
Rev. per Employee$453,105





 









 





































Most Popular





1.






O.J. Simpson made over $400,000 while in prison and won’t have to give any of it to the Goldman family






2.





Earnings Outlook

Alphabet earnings: A $2.74 billion hit for Google, potential YouTube results for investors






3.





Market Snapshot

Stocks brace for volatility in earnings deluge; Fed meeting looms 






4.





The Tell

Bitcoin surges as miners avert split for now






5.






Andy Serkis on 'The Greatest Acting Tool of the 21st Century'








Find a Broker

Partner Center »























Featured Stories





Seeing America again through new eyes







How to dig yourself out of debt







Move over, Tesla? Karma unveils its hybrid sports car







The salary you need to afford a home in these 25 cities







Why OPEC will never cut production again













Log In




12:47 PM EDT
July 23, 2017


/marketstate/country/us
New York

	Closed


/marketstate/country/uk
London

	Closed


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
12:28pThis is what might be next for O.J. Simpson after parole
12:09pWeekend roundup: Companies that may cut dividends | FAANG stocks and market bubbles | Enjoy London on the cheap
12:09pWhy you might want to avoid these 30 dividend stocks
12:09pAttention, shoppers: ‘Amazon effect’ is creating bargain stocks
12:05pAs GDP will show, U.S. economy on same track
12:00pStocks brace for volatility in earnings deluge; Fed meeting looms
11:52a'Dunkirk' storms U.S. box office with $50.5 million debut
11:27aO.J. Simpson made over $400,000 while in prison and won’t have to give any of it to the Goldman family
11:20aActor John Heard, ‘Home Alone’ dad, dead at 71
11:07aMicrosoft rides huge tax benefit from failing at smartphones to big earnings beat 
11:06aAmazon’s foray into groceries means more mergers of food companies, experts say
11:03aYogaWorks IPO pulled on valuation concerns, not market conditions
11:03aQualcomm’s issues go beyond Apple fight
11:02aPay TV expected to lose more than a million subscribers in latest quarter 
11:02aExxon earnings: Will stock trade higher on expected second-quarter beat?
11:01aAlphabet earnings: A $2.74 billion hit for Google, potential YouTube results for investors
11:01aChipotle earnings: Media coverage of the latest illness scare will put earnings targets at risk
11:01aNolan’s cinematic vision in ‘Dunkirk’ is Hollywood’s best defense against Netflix
11:00aGE earnings: Departing CEO Immelt’s last chance to bring good things to investors
10:59aBitcoin surges as miners avert split for now
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,580.07

-31.71
-0.15%





nasdaq

/quotes/zigman/12633936/realtime
6,387.75

-2.25
-0.04%





s&p 500

/quotes/zigman/3870025/realtime
2,472.54

-0.91
-0.04%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15
































































Michael  Ohalleran's Phone & Address | PeopleByName















 
Contact
Login










 Home
People Alphabetically
O
Ohalleran

Michael  Ohalleran




People directory with over 600,000,000 names!

Record ID: 395902785Michael  Ohalleran299 Oak AveLindenhurst, NY 11757(631) 583-8112Background Check - Available
Record ID: 395902786Michael  Ohalleran935 BroadwayMassapequa, NY 11758(516) 798-2332Background Check - Available
Record ID: 395902787Michael  Ohalleran299 Oak StMassapequa Park, NY 11762Age 74 (Born 1943)(631) 583-0125Background Check - Available
Record ID: 395902788Michael  Ohalleran299 Oak WalkBay Shore, NY 11706(631) 583-0125Background Check - Available
Record ID: 395902789Michael  Ohalleran299 Oak WkBay Shore, NY 11706(631) 583-8066Background Check - Available
Record ID: 395902856Michael D Ohalleran606 Lake Shore DrFontana, WI 53125Background Check - Available
Record ID: 395902857Michael D Ohalleran481 Lakeshore DrFontana, WI 53125(262) 275-9395Background Check - Available
Record ID: 395902858Michael D Ohalleran140 Evergreen LnWinnetka, IL 60093Age 67 (Born May 1950)(847) 446-7934Background Check - Available
Record ID: 395902873Michael O Ohalleran1010 Swallowtail DrPort Orange, FL 32129Age 58 (Born 1959)Background Check - Available
Record ID: 395902874Michael O Ohalleran2 Park DrMassapequa Park, NY 11762Age 58 (Born 1959)(516) 795-6850Background Check - Available
Record ID: 395902915Michael P Ohalleran68 Brittany LnGrayslake, IL 60030Age 40 (Born 1977)Background Check - Available
Record ID: 395902916Michael P Ohalleran1108 Bonita LnMchenry, IL 60050Age 40 (Born 1977)(815) 344-2836Background Check - Available
Record ID: 395902917Michael W Ohalleran915 North AveMchenry, IL 60051Age 57 (Born Jul 1960)(815) 344-6186Background Check - Available
Record ID: 395902918Michael W Ohalleran915 Center StMchenry, IL 60050Age 57 (Born Jul 1960)(815) 344-6186Background Check - Available
Record ID: 428923648Michael  Ohalleran299 Oak WkBay Shore, NY 11706(631) 583-8066Background Check - Available
Record ID: 428923649Michael  Ohalleran299 Oak StMassapequa Park, NY 11762Age 74 (Born 1943)(631) 583-0125Background Check - Available
Record ID: 428923650Michael  Ohalleran299 Oak AveLindenhurst, NY 11757(631) 583-8112Background Check - Available
Record ID: 428923651Michael  Ohalleran299 Oak WalkBay Shore, NY 11706(631) 583-0125Background Check - Available
Record ID: 428923652Michael  Ohalleran935 BroadwayMassapequa, NY 11758(516) 798-2332Background Check - Available
Record ID: 428923653Michael P Ohalleran1108 Bonita LnMchenry, IL 60050Age 40 (Born 1977)(815) 344-2836Background Check - Available
Record ID: 428923654Michael P Ohalleran68 Brittany LnGrayslake, IL 60030Age 40 (Born 1977)Background Check - Available
Record ID: 428923655Michael W Ohalleran915 North AveMchenry, IL 60051Age 57 (Born Jul 1960)(815) 344-6186Background Check - Available
Record ID: 428923656Michael W Ohalleran915 Center StMchenry, IL 60050Age 57 (Born Jul 1960)(815) 344-6186Background Check - Available
Record ID: 428923657Michael O Ohalleran1010 Swallowtail DrPort Orange, FL 32129Age 58 (Born 1959)(386) 788-3154Background Check - Available
Record ID: 428923658Michael O Ohalleran2 Park DrMassapequa Park, NY 11762Age 58 (Born 1959)(516) 795-6850Background Check - Available
Record ID: 428923659Michael D Ohalleran606 Lake Shore DrFontana, WI 53125Background Check - Available
Record ID: 428923660Michael D Ohalleran140 Evergreen LnWinnetka, IL 60093Age 67 (Born May 1950)(847) 446-7934Background Check - Available
Record ID: 428923661Michael D Ohalleran481 Lakeshore DrFontana, WI 53125(262) 275-9395Background Check - Available
Record ID: 612508081Michael  Ohalleran299 Oak AveLindenhurst, NY 11757(631) 583-8112Background Check - Available
Record ID: 612508082Michael  Ohalleran299 Oak WalkBay Shore, NY 11706(631) 583-0125Background Check - Available
Record ID: 612508083Michael  Ohalleran935 BroadwayMassapequa, NY 11758(516) 798-2332Background Check - Available
Record ID: 612508084Michael  Ohalleran299 Oak StMassapequa Park, NY 11762(631) 583-0125Background Check - Available
Record ID: 612508085Michael  Ohalleran299 Oak WkBay Shore, NY 11706(631) 583-8066Background Check - Available
Record ID: 612508136Michael D Ohalleran481 Lakeshore DrFontana, WI 53125(262) 275-9395Background Check - Available
Record ID: 612508137Michael D Ohalleran606 Lake Shore DrFontana, WI 53125Background Check - Available
Record ID: 612508138Michael D Ohalleran140 Evergreen LnWinnetka, IL 60093(847) 446-7934Background Check - Available
Record ID: 612508163Michael O Ohalleran1010 Swallowtail DrPort Orange, FL 32129(386) 788-3154Background Check - Available
Record ID: 612508164Michael O Ohalleran2 Park DrMassapequa Park, NY 11762(516) 795-6850Background Check - Available
Record ID: 612508209Michael P Ohalleran68 Brittany LnGrayslake, IL 60030(847) 543-9338Background Check - Available
Record ID: 612508210Michael P Ohalleran1108 Bonita LnMchenry, IL 60050(815) 344-2836Background Check - Available
Record ID: 612508218Michael W Ohalleran915 North AveMchenry, IL 60051(815) 344-6186Background Check - Available
Record ID: 612508219Michael W Ohalleran915 Center StMchenry, IL 60050(815) 344-6186Background Check - Available
Record ID: 617742853Michael  Ohalleran299 Oak WalkBay Shore, NY 11706(631) 583-0125Background Check - Available
Record ID: 617742854Michael  Ohalleran935 BroadwayMassapequa, NY 11758(516) 798-2332Background Check - Available
Record ID: 617742855Michael  Ohalleran299 Oak AveLindenhurst, NY 11757(631) 583-8112Background Check - Available
Record ID: 617742856Michael  Ohalleran299 Oak WkBay Shore, NY 11706(631) 583-8066Background Check - Available
Record ID: 617742857Michael  Ohalleran299 Oak StMassapequa Park, NY 11762(631) 583-0125Background Check - Available
Record ID: 617742902Michael O Ohalleran1010 Swallowtail DrPort Orange, FL 32129(386) 788-3154Background Check - Available
Record ID: 617742903Michael O Ohalleran2 Park DrMassapequa Park, NY 11762(516) 795-6850Background Check - Available
Record ID: 617742907Michael D Ohalleran140 Evergreen LnWinnetka, IL 60093(847) 446-7934Background Check - Available
Record ID: 617742908Michael D Ohalleran481 Lakeshore DrFontana, WI 53125(262) 275-9395Background Check - Available
Record ID: 617742909Michael D Ohalleran606 Lake Shore DrFontana, WI 53125Background Check - Available
Record ID: 617742943Michael P Ohalleran68 Brittany LnGrayslake, IL 60030(847) 543-9338Background Check - Available
Record ID: 617742944Michael P Ohalleran1108 Bonita LnMchenry, IL 60050(815) 344-2836Background Check - Available
Record ID: 617742965Michael W Ohalleran915 North AveMchenry, IL 60051(815) 344-6186Background Check - Available
Record ID: 617742966Michael W Ohalleran915 Center StMchenry, IL 60050(815) 344-6186Background Check - Available
Record ID: 756598581Michael  Ohalleran299 Oak WkBay Shore, NY 11706(631) 583-8066Background Check - Available
Record ID: 756598582Michael  Ohalleran299 Oak StMassapequa Park, NY 11762Age 74 (Born 1943)(631) 583-0125Background Check - Available
Record ID: 756598583Michael  Ohalleran299 Oak AveLindenhurst, NY 11757(631) 583-8112Background Check - Available
Record ID: 756598584Michael  Ohalleran299 Oak WalkBay Shore, NY 11706(631) 583-0125Background Check - Available
Record ID: 756598585Michael  Ohalleran935 BroadwayMassapequa, NY 11758(516) 798-2332Background Check - Available
Record ID: 756598586Michael P Ohalleran1108 Bonita LnMchenry, IL 60050Age 40 (Born 1977)(815) 344-2836Background Check - Available
Record ID: 756598587Michael P Ohalleran68 Brittany LnGrayslake, IL 60030Age 40 (Born 1977)Background Check - Available
Record ID: 756598588Michael W Ohalleran915 North AveMchenry, IL 60051Age 57 (Born Jul 1960)(815) 344-6186Background Check - Available
Record ID: 756598589Michael W Ohalleran915 Center StMchenry, IL 60050Age 57 (Born Jul 1960)(815) 344-6186Background Check - Available
Record ID: 756598590Michael O Ohalleran1010 Swallowtail DrPort Orange, FL 32129Age 58 (Born 1959)(386) 788-3154Background Check - Available
Record ID: 756598591Michael O Ohalleran2 Park DrMassapequa Park, NY 11762Age 58 (Born 1959)(516) 795-6850Background Check - Available
Record ID: 756598592Michael D Ohalleran606 Lake Shore DrFontana, WI 53125Background Check - Available
Record ID: 756598593Michael D Ohalleran140 Evergreen LnWinnetka, IL 60093Age 67 (Born May 1950)(847) 446-7934Background Check - Available
Record ID: 756598594Michael D Ohalleran481 Lakeshore DrFontana, WI 53125(262) 275-9395Background Check - Available








 


 




1,379,043,021 total records available




Tweet





  Testimonials Read testimonials from real customers who already used our services. Read More

  Webmasters Earn 75% commission on every sale you drive to our website. Weekly payouts! Read More

   Mobile Version Visit us from your smart phone anywhere you are. Read More

   Recent Lookups Check out the most recent reverse phone lookups on PeopleByName.com Read More

 



 Home Mobile Version Phone Directory People Directory Remove information
 Terms of Service Privacy Policy Affiliate Program About Us 
 Member Login Frequently Asked Questions Contact Us Testimonials 
 Careers Product & Services Volume Discounts Site Map 




© PeopleByName All Rights Reserved. 2010-2017















Michael D. O’Halleran And Patrick S. Miles Elected To Nuvasive Board Of Directors | NuVasive







































 













Search for:






search
Created with Sketch.

















Menu










NuVasive























By Andrew Nurre
12:00 AM on August, 1 2016

Michael D. O’Halleran And Patrick S. Miles Elected To  Nuvasive Board Of Directors


SAN DIEGO, CA – August 1, 2016 – NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the appointment of Mike O’Halleran and Pat Miles to the Company’s Board of Directors effective August 1, 2016. Mr. O’Halleran will serve as an independent director of the Company and member of the Board’s Audit Committee. Mr. Miles currently serves as president and chief operating officer (COO) of NuVasive, Inc. and is a member of the Company’s executive management team. Mr. Miles will serve as a non-independent member of the Board.
“We are pleased to welcome Mike and Pat to our Board of Directors as we work to advance the long-term strategic goals of NuVasive. Mike and Pat are extremely accomplished leaders who bring a wealth of experience and judgment to our Board,” said Gregory T. Lucier, chairman and chief executive officer of NuVasive, Inc. “Mike’s extensive business experience and Pat’s deep understanding of the dynamics of the spine industry will complement the skills of our current Board and add value to the future of the Company.”
With more than 40 years of business experience, Mr. O’Halleran currently serves as the executive chairman of Aon Benfield and senior vice president of Aon, plc, a provider of risk management, insurance and consulting services. Mr. O’Halleran joined the Aon group of companies in 1987 to lead its reinsurance division and since that time, has served in several significant management positions including president and chief operating officer of Aon Corporation, and since August 2007, as the executive chairman of Aon Benfield. Prior to joining Aon, he was a senior executive with well-known companies in the insurance industry. Mr. O’Halleran brings extensive healthcare and medical device governance experience, having been a long-standing director of Cardinal Health and later CareFusion. Mr. O’Halleran has a degree in Accounting and Finance from the University of Wisconsin-Whitewater.
As an orthopedic and spine industry veteran with more than 25 years’ experience, Mr. Miles’ appointment to the Board reflects the impact he brings to the future of NuVasive. Mr. Miles has been with NuVasive since 2001, and has held multiple roles with increasing responsibility in the areas of operations, research, surgeon education, product development, and marketing. In 2015, he was appointed president and COO, responsible for leadership of NuVasive’s global products and services, as well as operational duties, including customer fulfillment, manufacturing, supply chain management and quality engineering. Prior to joining NuVasive, he held positions at Medtronic Sofamor Danek and Smith & Nephew. Mr. Miles received a B.S. in Finance from Mercer University.
About NuVasive
NuVasive, Inc. (NASDAQ: NUVA) is a world leader in minimally invasive, procedurally-integrated spine solutions. From complex spinal deformity to degenerative spinal conditions, NuVasive is transforming spine surgery with innovative technologies designed to deliver reproducible and clinically proven surgical outcomes. NuVasive’s highly differentiated, procedurally-integrated solutions include access instruments, implantable hardware and software systems for surgical planning and reconciliation technology that centers on achieving the global alignment of the spine. With $811 million in revenues (2015), NuVasive has an approximate 1,900 person workforce in more than 40 countries around the world. For more information, please visit nuvasive.com.
Forward-Looking Statements
NuVasive cautions you that statements included in this news release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive’s results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, among others, risks associated with acceptance of the Company’s surgical products and procedures by spine surgeons, development and acceptance of new products or product enhancements, clinical and statistical verification of the benefits achieved via the use of NuVasive’s products (including the iGA™ platform), the Company’s ability to effectually manage inventory as it continues to release new products, its ability to recruit and retain management and key personnel, and the other risks and uncertainties described in NuVasive’s news releases and periodic filings with the Securities and Exchange Commission. NuVasive’s public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.
# # #
Investor Contact:
Suzanne Hatcher
NuVasive, Inc.
858-458-2240
[email protected]
 
Media Contact:
Michael Farrington
NuVasive, Inc.
858-909-1940
[email protected]

Previous PostNext Post





Share

twitter
facebook
linkedin
googleplus
email

















The materials on this website are for your general educational information only. Information you read on this website cannot replace the relationship that you have with your healthcare professional. We do not practice medicine or provide medical services or advice as a part of this website. You should always talk to your healthcare professional for diagnosis and treatment. 




Terms & Conditions
Privacy
©2017 NuVasive®, Inc.








This site uses cookies to enhance your experience.
OK
Learn More












Solutions

Procedurally-Integrated SolutionsiGA®NVM5®NuVasive Clinical Services™NuVasive Specialized Orthopedics™LessRay® Back
Procedures

Spine

XLIF®XLIF CorpectomyPCFACDFMAS® PLIFMAS TLIFALIFMAGEC® SystemThoracolumbar Posterior Fixation Back 
Limb Lengthening

PRECICE® System Back 
Featured Offerings

BiologicsBendini®RELINE® Back 
 Back
Conditions

Spine

Lumbar Degenerative Disc DiseaseLumbar Spinal StenosisDegenerative SpondylolisthesisDegenerative ScoliosisCervical Disc DegenerationBack PainEarly Onset Scoliosis Back 
Femur / Tibia

Limb Length Discrepancy Back 
 Back
Resources

For Patients

The Better Way Back™SpineTRACK Registry Back 
For Surgeons

Education & TrainingReimbursementElectronic IFU InformationVirtual Patent MarkingSpineTRACK RegistryPCM Data Collection FormNuvaMap®PRECICE Physicians Back 
 Back
ServicesAbout

LeadershipNews & EventsCorporate IntegrityNuVasive Spine FoundationNuVasive Corporate Grants Back
CareersInvestor Relations

Online IR KitFAQsPress ReleasesWebcasts and EventsStock InformationGovernanceSEC FilingsAnnual Reports Back
Electronic IFU InformationContactInternational Sites

NuVasive® JapanNuVasive® Germany Back
 















Michael D. O'Halleran and Patrick S. Miles Elected to NuVasive Board of DirectorsHomeMailFlickrTumblrNewsSportsFinanceCelebrityAnswersGroupsMobileMoreTry Yahoo Finance on Firefox »YahooSearchSearchSign inU.S. Markets closedS&P 5002,472.54-0.91 (-0.04%)Dow 3021,580.07-31.71 (-0.15%)Nasdaq6,387.75-2.25 (-0.04%)LISTENAetna's CEO Mark Bertolini on the future of the health care systemBertolini shares how a life-threatening injury shaped his views on health care.Michael D. O'Halleran and Patrick S. Miles Elected to NuVasive Board of DirectorsMarketwiredAugust 1, 2016ReblogShareTweetShareSAN DIEGO, CA--(Marketwired - August 01, 2016) - NuVasive, Inc. (NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the appointment of Mike O'Halleran and Pat Miles to the Company's Board of Directors effective August 1, 2016. Mr. O'Halleran will serve as an independent director of the Company and member of the Board's Audit Committee. Mr. Miles currently serves as president and chief operating officer (COO) of NuVasive, Inc. and is a member of the Company's executive management team. Mr. Miles will serve as a non-independent member of the Board."We are pleased to welcome Mike and Pat to our Board of Directors as we work to advance the long-term strategic goals of NuVasive. Mike and Pat are extremely accomplished leaders who bring a wealth of experience and judgment to our Board," said Gregory T. Lucier, chairman and chief executive officer of NuVasive, Inc. "Mike's extensive business experience and Pat's deep understanding of the dynamics of the spine industry will complement the skills of our current Board and add value to the future of the Company."With more than 40 years of business experience, Mr. O'Halleran currently serves as the executive chairman of Aon Benfield and senior vice president of Aon, plc, a provider of risk management, insurance and consulting services. Mr. O'Halleran joined the Aon group of companies in 1987 to lead its reinsurance division and since that time, has served in several significant management positions including president and chief operating officer of Aon Corporation, and since August 2007, as the executive chairman of Aon Benfield. Prior to joining Aon, he was a senior executive with well-known companies in the insurance industry. Mr. O'Halleran brings extensive healthcare and medical device governance experience, having been a long-standing director of Cardinal Health and later CareFusion. Mr. O'Halleran has a degree in Accounting and Finance from the University of Wisconsin-Whitewater.As an orthopedic and spine industry veteran with more than 25 years' experience, Mr. Miles' appointment to the Board reflects the impact he brings to the future of NuVasive. Mr. Miles has been with NuVasive since 2001, and has held multiple roles with increasing responsibility in the areas of operations, research, surgeon education, product development, and marketing. In 2015, he was appointed president and COO, responsible for leadership of NuVasive's global products and services, as well as operational duties, including customer fulfillment, manufacturing, supply chain management and quality engineering. Prior to joining NuVasive, he held positions at Medtronic Sofamor Danek and Smith & Nephew. Mr. Miles received a B.S. in Finance from Mercer University.About NuVasiveNuVasive, Inc. (NUVA) is a world leader in minimally invasive, procedurally-integrated spine solutions. From complex spinal deformity to degenerative spinal conditions, NuVasive is transforming spine surgery with innovative technologies designed to deliver reproducible and clinically proven surgical outcomes. NuVasive's highly differentiated, procedurally-integrated solutions include access instruments, implantable hardware and software systems for surgical planning and reconciliation technology that centers on achieving the global alignment of the spine. With $811 million in revenues (2015), NuVasive has an approximate 1,900 person workforce in more than 40 countries around the world. For more information, please visit nuvasive.com.Forward-Looking StatementsNuVasive cautions you that statements included in this news release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, among others, risks associated with acceptance of the Company's surgical products and procedures by spine surgeons, development and acceptance of new products or product enhancements, clinical and statistical verification of the benefits achieved via the use of NuVasive's products (including the iGA™ platform), the Company's ability to effectually manage inventory as it continues to release new products, its ability to recruit and retain management and key personnel, and the other risks and uncertainties described in NuVasive's news releases and periodic filings with the Securities and Exchange Commission. NuVasive's public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.ReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextWhy it might be ‘dangerous’ for IBM to turn itself around: professorYahoo FinanceStarbucks exec responds to criticism of company's jargon with playful letterPuget Sound Business JournalThis NBA player already owns 18 companies — but he visited Silicon Valley to learn more about entrepreneurshipBusiness InsiderHere Is the Best Railroad Stock to Own, Jim Cramer SaysThe StreetHow Satya Nadella has rebooted MicrosoftThe StreetWhy sparkling water sales could spike by 20% in 2017Yahoo FinanceWhat it's like to ship yourself overnight on Cabin's sleep pod busTechCrunchIntercepted communications appear to contradict Jeff Sessions' claims about his conversations with Russian ambassadorBusiness InsiderAetna CEO Bertolini: How tech plays into the future of healthcareYahoo Finance VideoCall of the week: Now's the time to 'buy' ChipotleYahoo FinanceFund manager explains why he estimates Putin's net worth to be $200 billionYahoo Finance'Out and out political warfare': Trump claims 'complete power to pardon' amid the White House's escalating war on Russia investigationBusiness InsiderAetna's CEO Mark Bertolini on the future of the health care systemYahoo FinanceAetna CEO Bertolini: Why he pays his employees to sleepYahoo Finance VideoShort-sellers have lost $7.1 billion betting against this year's hottest tech stocksYahoo FinanceOne month after Tim Tebow's ridiculed promotion, he is on fireBusiness InsiderPolls Show Trump, the Least Popular President Ever, Is Plunging Even LowerLarry: It still frightens me to know that 35% of our citizenry are either gullible or just plain stupid.Join the Conversation1 / 55.2k














									Michael D. O'Halleran and Patrick S. Miles Elected to NuVasive Board of Directors |
									Newswire
			



































 




Michael D. O'Halleran and Patrick S. Miles Elected to NuVasive Board of Directors


Press Release
-

												Jul 31, 2016						
 


			July 31, 2016			(Press Release) -
	 SAN DIEGO, CA - NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the appointment of Mike O'Halleran and Pat Miles to the Company's Board of Directors effective August 1, 2016. Mr. O'Halleran will serve as an independent director of the Company and member of the Board's Audit Committee. Mr. Miles currently serves as president and chief operating officer (COO) of NuVasive, Inc. and is a member of the Company's executive management team. Mr. Miles will serve as a non-independent member of the Board.
"We are pleased to welcome Mike and Pat to our Board of Directors as we work to advance the long-term strategic goals of NuVasive. Mike and Pat are extremely accomplished leaders who bring a wealth of experience and judgment to our Board," said Gregory T. Lucier, chairman and chief executive officer of NuVasive, Inc. "Mike's extensive business experience and Pat's deep understanding of the dynamics of the spine industry will complement the skills of our current Board and add value to the future of the Company."
With more than 40 years of business experience, Mr. O'Halleran currently serves as the executive chairman of Aon Benfield and senior vice president of Aon, plc, a provider of risk management, insurance and consulting services. Mr. O'Halleran joined the Aon group of companies in 1987 to lead its reinsurance division and since that time, has served in several significant management positions including president and chief operating officer of Aon Corporation, and since August 2007, as the executive chairman of Aon Benfield. Prior to joining Aon, he was a senior executive with well-known companies in the insurance industry. Mr. O'Halleran brings extensive healthcare and medical device governance experience, having been a long-standing director of Cardinal Health and later CareFusion. Mr. O'Halleran has a degree in Accounting and Finance from the University of Wisconsin-Whitewater. 
As an orthopedic and spine industry veteran with more than 25 years' experience, Mr. Miles' appointment to the Board reflects the impact he brings to the future of NuVasive. Mr. Miles has been with NuVasive since 2001, and has held multiple roles with increasing responsibility in the areas of operations, research, surgeon education, product development, and marketing. In 2015, he was appointed president and COO, responsible for leadership of NuVasive's global products and services, as well as operational duties, including customer fulfillment, manufacturing, supply chain management and quality engineering. Prior to joining NuVasive, he held positions at Medtronic Sofamor Danek and Smith & Nephew. Mr. Miles received a B.S. in Finance from Mercer University. 
About NuVasive
NuVasive, Inc. (NASDAQ: NUVA) is a world leader in minimally invasive, procedurally-integrated spine solutions. From complex spinal deformity to degenerative spinal conditions, NuVasive is transforming spine surgery with innovative technologies designed to deliver reproducible and clinically proven surgical outcomes. NuVasive's highly differentiated, procedurally-integrated solutions include access instruments, implantable hardware and software systems for surgical planning and reconciliation technology that centers on achieving the global alignment of the spine. With $811 million in revenues (2015), NuVasive has an approximate 1,900 person workforce in more than 40 countries around the world. For more information, please visit nuvasive.com.
Forward-Looking Statements
NuVasive cautions you that statements included in this news release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, among others, risks associated with acceptance of the Company's surgical products and procedures by spine surgeons, development and acceptance of new products or product enhancements, clinical and statistical verification of the benefits achieved via the use of NuVasive's products (including the iGA™ platform), the Company's ability to effectually manage inventory as it continues to release new products, its ability to recruit and retain management and key personnel, and the other risks and uncertainties described in NuVasive's news releases and periodic filings with the Securities and Exchange Commission. NuVasive's public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.
Source URL: http://www.marketwired.com/mw/release.do?id=2146793&sourceType=3




		Share on Facebook
	


		Share on Twitter
	









Categories:
Medicine and Healthcare 





About NuVasive, Inc.

View Website

NuVasive is an innovative medical device company specializing in minimally disruptive surgical products and optimizing the surgical process for the spine.














									More Press Releases
								






NuVasive Announces Conference Call and Webcast of Fourth Quarter 2016 Results

NuVasive, Inc.
-
Jan 13, 2017





NuVasive Announces Select Preliminary Unaudited Full Year 2016 Financial Results and 2017 Outlook

NuVasive, Inc.
-
Jan 9, 2017





NuVasive to Present at the 35th Annual J.P. Morgan Healthcare Conference

NuVasive, Inc.
-
Jan 4, 2017













 









 



























 




			Newswire		



 




Get notified about new releases.
Sign up for email updates from Newswire.




Enter your email address



Notification Frequency 



Press Releases


Instant



Daily



Never



News


Instant



Daily



Never



Event


Instant



Daily



Never



Blog



Daily



Never



Facebook



Daily



Never



Twitter



Daily



Never





Subscribe


 




 













Michael D. O'Halleran and Patrick S. Miles Elected to NuVasive Board of Directors, by @marketwired








back
                













3





















 Articles
                    











                            @marketwired/michael-d-ohalleran-and-patrick-s-miles-elected-to-nuvasive-board-of-directors
                         channel
                    


















Get CEO.CA Pro
Real-time Level 2 Market Depth





featured articles






July 21, 2017

@Haywood HAYWOOD RESEARCH: The Weekly Dig - Canadian Mining Equity Performance Muted Despite Gold Price Bump








July 19, 2017

@Goldfinger Sabina Gets A Green Light
$SBB








July 18, 2017

@tommy Why I'm marketing Leagold
$LMC








July 15, 2017

@Goldfinger A Perfect Storm Is Brewing For A Precious Metals Rally



show more ▾




sponsors



$AVU Avrupa recovers 100% ownership of Alvalade VMS Project




$DV The 2017 Exploration Program Has Commenced On The Dolly Varden Project In Northwestern British Columbia, Canada




$LIX Lithium X to Acquire Aberdeen Interest to Consolidate 100% Ownership of the Sal de los Angeles Project




$KTO K2 Gold Commences Drilling at the Wels Gold Property, Yukon




$AAN Aton Returns 28 Metres Of 2.84 Grams Per Tonne Gold Equivalent From Hamama West




$MRL Margaux Resources Commissions NI 43-101 Compliant Technical Report on its Sheep Creek Gold Property




$PGX Prosper Gold Corp. Begins 10,000 m Drill Program Ashley Gold Project - Northern Ontario








                Articles
            









            
            @marketwired/michael-d-ohalleran-and-patrick-s-miles-elected-to-nuvasive-board-of-directors
        


                    0 online
                
            





 subscribe






            Members of
            @marketwired/michael-d-ohalleran-and-patrick-s-miles-elected-to-nuvasive-board-of-directors
            
            
        

Moderators




Members

















                by @marketwired on August 1, 2016 
                
            
Michael D. O'Halleran and Patrick S. Miles Elected to NuVasive Board of Directors












 SAN DIEGO, CA--(Marketwired - August 01, 2016) - NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the appointment of Mike O'Halleran and Pat Miles to the Company's Board of Directors effective August 1, 2016. Mr. O'Halleran will serve as an independent director of the Company and member of the Board's Audit Committee. Mr. Miles currently serves as president and chief operating officer (COO) of NuVasive, Inc. and is a member of the Company's executive management team. Mr. Miles will serve as a non-independent member of the Board."We are pleased to welcome Mike and Pat to our Board of Directors as we work to advance the long-term strategic goals of NuVasive. Mike and Pat are extremely accomplished leaders who bring a wealth of experience and judgment to our Board," said Gregory T. Lucier, chairman and chief executive officer of NuVasive, Inc. "Mike's extensive business experience and Pat's deep understanding of the dynamics of the spine industry will complement the skills of our current Board and add value to the future of the Company."With more than 40 years of business experience, Mr. O'Halleran currently serves as the executive chairman of Aon Benfield and senior vice president of Aon, plc, a provider of risk management, insurance and consulting services. Mr. O'Halleran joined the Aon group of companies in 1987 to lead its reinsurance division and since that time, has served in several significant management positions including president and chief operating officer of Aon Corporation, and since August 2007, as the executive chairman of Aon Benfield. Prior to joining Aon, he was a senior executive with well-known companies in the insurance industry. Mr. O'Halleran brings extensive healthcare and medical device governance experience, having been a long-standing director of Cardinal Health and later CareFusion. Mr. O'Halleran has a degree in Accounting and Finance from the University of Wisconsin-Whitewater. As an orthopedic and spine industry veteran with more than 25 years' experience, Mr. Miles' appointment to the Board reflects the impact he brings to the future of NuVasive. Mr. Miles has been with NuVasive since 2001, and has held multiple roles with increasing responsibility in the areas of operations, research, surgeon education, product development, and marketing. In 2015, he was appointed president and COO, responsible for leadership of NuVasive's global products and services, as well as operational duties, including customer fulfillment, manufacturing, supply chain management and quality engineering. Prior to joining NuVasive, he held positions at Medtronic Sofamor Danek and Smith & Nephew. Mr. Miles received a B.S. in Finance from Mercer University. About NuVasiveNuVasive, Inc. (NASDAQ: NUVA) is a world leader in minimally invasive, procedurally-integrated spine solutions. From complex spinal deformity to degenerative spinal conditions, NuVasive is transforming spine surgery with innovative technologies designed to deliver reproducible and clinically proven surgical outcomes. NuVasive's highly differentiated, procedurally-integrated solutions include access instruments, implantable hardware and software systems for surgical planning and reconciliation technology that centers on achieving the global alignment of the spine. With $811 million in revenues (2015), NuVasive has an approximate 1,900 person workforce in more than 40 countries around the world. For more information, please visit nuvasive.com.Forward-Looking StatementsNuVasive cautions you that statements included in this news release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, among others, risks associated with acceptance of the Company's surgical products and procedures by spine surgeons, development and acceptance of new products or product enhancements, clinical and statistical verification of the benefits achieved via the use of NuVasive's products (including the iGA™ platform), the Company's ability to effectually manage inventory as it continues to release new products, its ability to recruit and retain management and key personnel, and the other risks and uncertainties described in NuVasive's news releases and periodic filings with the Securities and Exchange Commission. NuVasive's public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.
Investor Contact:Suzanne HatcherNuVasive, Inc.858-458-2240Email contactMedia Contact:Michael FarringtonNuVasive, Inc.858-909-1940Email contact


















No more messages to load
see older messages




see newer messages or go to most recent






















Log in
Sign up







home
                            
                            
                        



feed
                            
                            
                        





                    Featured
                



index
                            
                            
                        



popular
                            
                            
                        



editors
                            
                            
                        



articles
                            
                            
                        



newsroom
                            
                            
                        



insiders
                            
                            
                        



feedback
                            
                            
                        





                    Sponsors
                



$PGX
                            
                                
                                
0.200
                                




$KTO
                            
                                
                                
0.375
                                




$AAN
                            
                                
                                
0.035
                                




$MRL
                            
                                
                                
0.300
                                




$AVU
                            
                                
                                
0.105
                                




$LIX
                            
                                
                                
2.13
                                




$DV
                            
                                
                                
0.470
                                





Settings


 Toggle sound


$ Toggle quote display








            Personal channels
        





×



Mobile Investment Conference

                    Share knowledge and track stocks in real-time among CEOs and market pros.
                

                Request Invite!
            


I agree to the CEO.CA Terms of Use and Privacy Policy





Already a member?
Log in now.
            

Want to learn more?
Visit the About page.
            



Log in



Log in

                forgot your password?
            





































































403 - Forbidden: Access is denied.



Server Error


403 - Forbidden: Access is denied.
You do not have permission to view this directory or page using the credentials that you supplied.










Michael D. O’Halleran and Patrick S. Miles Elected to NuVasive Board of Directors |













































































































Spine
Michael D. O’Halleran and Patrick S. Miles Elected to NuVasive Board of Directors

Posted by  Drue De Angelis
on 12 months ago 





More in Spine:



Medtronic Announces Infuse Settlements
2 days ago



If You Have Lumbar Spinal Stenosis, There’s an Exciting New Option
3 days ago



North America Spinal Implants Market CAGR of 5.1% 2024
3 days ago





Share this story with your networkFacebook9TwitterGoogle+1Pinterest1


SAN DIEGO, CA–(Marketwired – August 01, 2016) – NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the appointment of Mike O’Halleran and Pat Miles to the Company’s Board of Directors effective August 1, 2016. Mr. O’Halleran will serve as an independent director of the Company and member of the Board’s Audit Committee. Mr. Miles currently serves as president and chief operating officer (COO) of NuVasive, Inc. and is a member of the Company’s executive management team. Mr. Miles will serve as a non-independent member of the Board.
“We are pleased to welcome Mike and Pat to our Board of Directors as we work to advance the long-term strategic goals of NuVasive. Mike and Pat are extremely accomplished leaders who bring a wealth of experience and judgment to our Board,” said Gregory T. Lucier, chairman and chief executive officer of NuVasive, Inc. “Mike’s extensive business experience and Pat’s deep understanding of the dynamics of the spine industry will complement the skills of our current Board and add value to the future of the Company.”
With more than 40 years of business experience, Mr. O’Halleran currently serves as the executive chairman of Aon Benfield and senior vice president of Aon, plc, a provider of risk management, insurance and consulting services. Mr. O’Halleran joined the Aon group of companies in 1987 to lead its reinsurance division and since that time, has served in several significant management positions including president and chief operating officer of Aon Corporation, and since August 2007, as the executive chairman of Aon Benfield. Prior to joining Aon, he was a senior executive with well-known companies in the insurance industry. Mr. O’Halleran brings extensive healthcare and medical device governance experience, having been a long-standing director of Cardinal Health and later CareFusion. Mr. O’Halleran has a degree in Accounting and Finance from the University of Wisconsin-Whitewater.
As an orthopedic and spine industry veteran with more than 25 years’ experience, Mr. Miles’ appointment to the Board reflects the impact he brings to the future of NuVasive. Mr. Miles has been with NuVasive since 2001, and has held multiple roles with increasing responsibility in the areas of operations, research, surgeon education, product development, and marketing. In 2015, he was appointed president and COO, responsible for leadership of NuVasive’s global products and services, as well as operational duties, including customer fulfillment, manufacturing, supply chain management and quality engineering. Prior to joining NuVasive, he held positions at Medtronic Sofamor Danek and Smith & Nephew. Mr. Miles received a B.S. in Finance from Mercer University.
About NuVasive
NuVasive, Inc. (NASDAQ: NUVA) is a world leader in minimally invasive, procedurally-integrated spine solutions. From complex spinal deformity to degenerative spinal conditions, NuVasive is transforming spine surgery with innovative technologies designed to deliver reproducible and clinically proven surgical outcomes. NuVasive’s highly differentiated, procedurally-integrated solutions include access instruments, implantable hardware and software systems for surgical planning and reconciliation technology that centers on achieving the global alignment of the spine. With $811 million in revenues (2015), NuVasive has an approximate 1,900 person workforce in more than 40 countries around the world. For more information, please visit nuvasive.com.
Forward-Looking Statements
NuVasive cautions you that statements included in this news release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive’s results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, among others, risks associated with acceptance of the Company’s surgical products and procedures by spine surgeons, development and acceptance of new products or product enhancements, clinical and statistical verification of the benefits achieved via the use of NuVasive’s products (including the iGA™ platform), the Company’s ability to effectually manage inventory as it continues to release new products, its ability to recruit and retain management and key personnel, and the other risks and uncertainties described in NuVasive’s news releases and periodic filings with the Securities and Exchange Commission. NuVasive’s public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.
Contact Information
Investor Contact:
Suzanne Hatcher
NuVasive, Inc.
858-458-2240
Email contact
Media Contact:
Michael Farrington
NuVasive, Inc.
858-909-1940
Email contact











Leave a Comment Cancel 
Your email address will not be published. Required fields are marked *Message Name *
Email Address *
Website 
 

 Notify me of follow-up comments by email. Notify me of new posts by email. 





Recent
Paragon 28® expands innovative product portfolio with the launch of the PROMO™ Triplanar Hallux Valgus Correction SystemTissue Regenix Announces Proposed Acquisition of CellRight TechnologiesSingapore launches $13M 3D printing center with focus on medical researchMedtronic Announces Infuse SettlementsInvibio and Carbofix Partnering With UK Olympic Sprinter James Ellington on New “Passion For Progress” InitiativePopular

The single protein injection which could replace the need for knee surgery for osteoarthritis sufferers 72 comments
Pegasus Biologics is insolvent; Closing their doors 40 comments
THE SPINEBLOGGER 17 comments
NuVasive CEO: No Sign Of Economic Hit To Spinal Devices 8 comments
Win an iPod Shuffle 6 comments

Tweets
My Tweets
Follow us
Let's connect on any of these social networks!
































Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email. 
 

							Email Address						











Polls



With the acquisition of Spinal Elements, what do you expect to be the fate of Amendia?
 File for IPO
 Get Acquired
 Struggle to Integrate / Grow
 Status Quo
 Increased Growth but Stay Private
View Results


 Loading ...
Polls Archive 

OrthoSpineNews
 


















































